ABATTIS BIOCEUTICALS
Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and wellness solutions that address chronic illnesses and disease in animals and humans through proprietary and patent pending formulations. The Company has identified targeted channels to market and license proprietary patent pending products throughout the world. http://www.abattis.com/s/news.asp?ReportID=692690 SEDAR Filings: http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00011477
ABATTIS BIOCEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
1997-09-29
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.abattis.com
Total Employee:
11+
Status:
Active
Contact:
(604) 538-6650
Email Addresses:
[email protected]
Total Funding:
400.99 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-04-02 | Pro Natura BV | Pro Natura BV acquired by Abattis Bioceuticals | 6.68 M EUR |
2016-10-24 | Experion Bio Technologies Inc. | Experion Bio Technologies Inc. acquired by Abattis Bioceuticals | 7.5 M USD |
Official Site Inspections
http://www.abattis.com
- Host name: 104.21.4.100
- IP address: 104.21.4.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abattis Bioceuticals"
Abattis Bioceuticals - Crunchbase Company Profile & Funding
Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and โฆSee details»
Abattis Bioceuticals Corp. - Canadian Securities Exchange
Dec 23, 2010 Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries โฆSee details»
Abattis Bioceuticals Corp. (ATTBF) - Yahoo Finance
See the company profile for Abattis Bioceuticals Corp. (ATTBF) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Abattis Bioceuticals Corp (CSE: ATT) - LinkedIn
Abattis Bioceuticals is a life sciences company that aggregates and invests in biotechnology services internationally. | OUR STORY Abattis is publicly traded speciality agricultural โฆSee details»
Abattis Bioceuticals Corp. (ATTBF) - Yahoo Finance Canada
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and โฆSee details»
Abattis Bioceuticals Company Profile 2024: Valuation, Funding ...
Abattis Bioceuticals General Information Description. Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in โฆSee details»
ATTBF | Abattis Bioceuticals Corp. Profile | MarketWatch
Abattis Bioceuticals Corp. It produces, markets, and licenses proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets.See details»
Abattis and Management Overcome Legal and Regulatory
Mar 19, 2021 After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 ...See details»
Abattis Bioceuticals - Contacts, Employees, Board Members, โฆ
Abattis Bioceuticals has 10 current employee profiles, including CA, CFA as Vice President of Finance Jason Anderson. Abattis Bioceuticals has 2 board members and advisors, including โฆSee details»
Abattis Bioceuticals Narrowly Avoids Delisting from Canadian โฆ
Aug 9, 2019 Abattis appears to have avoided the delisting event thanks to finally filing its audited financial statements late last night. The firm reported sales of $8,371 for the year ended โฆSee details»
Abattis and Management Overcome Legal and Regulatory โฆ
Mar 19, 2021 After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication. VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) โฆSee details»
Abattis Announces Acquisition of European Nutraceutical โฆ
Abattis' products and services divisions include its Abattis-branded vaporizer line, as well as the proprietary cannabinoid therapeutic, COMFORTโข, formulated to treat chronic pain and โฆSee details»
Abattis Bioceuticals (ATT) Stock Price, News & Analysis - MarketBeat
5 days ago Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug โฆSee details»
Abbatis Bioceuticals Corp. Announces Launch Of Redesigned โฆ
Jun 17, 2014 Abattis Bioceuticals Corp. (OTCPINK: ATTBF) saw its share volume remain strong on June 17th with 1,316,503 shares exchanging hands, slightly higher than its three month โฆSee details»
Abattis Announces Acquisition of European Nutraceutical
Apr 2, 2019 The Acquisition Subsidiary has also agreed to pay Catalyst (i) a โฌ5,000,000 milestone payment within two years of Abattis CBD products being launched through Pro โฆSee details»
ATTBF Stock Price Quote | Morningstar
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services โฆSee details»
Abattis and Management Overcome Legal and Regulatory โฆ
Mar 19, 2021 Abattis was named in Order and the Notice of Hearing, but the Companyโs officers and directors were not. On January 16, 2019, the BCSC Panel revised the Order and Abattis โฆSee details»
Abattis and Management Overcome Legal and Regulatory โฆ
Mar 19, 2021 Abattis was named in Order and the Notice of Hearing, but the Companyโs officers and directors were not. On January 16, 2019, the BCSC Panel revised the Order and Abattis โฆSee details»
Abattis Bioceuticals Corp (ATTBF) Stock Price and News
Aug 24, 2010 Real-time Price Updates for Abattis Bioceuticals Corp (ATTBF), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Abattis Bioceuticals to Dispose of Cannabis Operations
Nov 9, 2019 Abattis will now begin the process of disposing of its cannabis-related operations over the coming months. The issuer currently owns Gabriola Green Farms, a โlate stageโ โฆSee details»